Home > Income Statement > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
Consolidated Net Profit

    Back to Income Statement
TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
Best 1M Momentum Large Cap Stocks
AD     Remove this Ad

TORRENT PHARMACEUTICALS Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹1,656 Cr₹1,245 Cr₹777 Cr₹1,252 Cr₹1,025 Cr

What is the latest Consolidated Net Profit of TORRENT PHARMACEUTICALS ?

The latest Consolidated Net Profit ratio of TORRENT PHARMACEUTICALS is ₹1,656 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹1,656 Cr
Mar2024₹1,245 Cr
Mar2023₹777 Cr
Mar2022₹1,252 Cr
Mar2021₹1,025 Cr

How is Consolidated Net Profit of TORRENT PHARMACEUTICALS Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹1,656 Cr
33.02
Mar2024 ₹1,245 Cr
60.22
Mar2023 ₹777 Cr
-37.92
Mar2022 ₹1,252 Cr
22.17
Mar2021 ₹1,025 Cr -

Compare Consolidated Net Profit of peers of TORRENT PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS ₹148,489.9 Cr 0.4% 8.2% 44.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹432,000.0 Cr -0.4% 5.3% 13.4% Stock Analytics
DIVIS LABORATORIES ₹161,076.0 Cr -4.3% -6.3% 12.3% Stock Analytics
DR REDDYS LABORATORIES ₹107,921.0 Cr 0.5% 1.8% 16.4% Stock Analytics
CIPLA ₹106,150.0 Cr -0.8% -2.6% -9.2% Stock Analytics
MANKIND PHARMA ₹88,243.3 Cr -1.1% 2.4% -4.6% Stock Analytics


TORRENT PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS

0.4%

8.2%

44.7%

SENSEX

-5.5%

-11.5%

0.3%


You may also like the below Video Courses